Abstract
Based on the cardiac metabolic changes during hypoxia, in this second part of our review we propose, the polarizing solution as an alternative for the maintenance of the cardiac cells during an infarction, in conjunction with other alternative therapies.
MeSH terms
-
Animals
-
Clinical Trials as Topic
-
Glucose / therapeutic use*
-
Humans
-
Hypoxia / metabolism*
-
Insulin / therapeutic use*
-
Monosaccharide Transport Proteins / therapeutic use*
-
Myocardial Ischemia / drug therapy
-
Myocardial Ischemia / metabolism*
-
Myocardium / metabolism*
-
Potassium / therapeutic use*
-
Rats
Substances
-
Insulin
-
Monosaccharide Transport Proteins
-
glucose-insulin-potassium cardioplegic solution
-
Glucose
-
Potassium